Company / Shares Outstanding
Idexx Laboratories Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
81.6M
FY2025
5-year range
81.6M / 85.4M
FY2021-FY2025
Trend
-1.7%
vs FY2024
Sector context
#89 of 165
Health Care
What the data says
At 81604000.00, Idexx Laboratories's shares outstanding ranks #77 of 165 in the Health Care sector.
Based on SEC 10-K filings.
81604000.00 in FY2025 with a 5-year CAGR of -0.9%.
Remained stable around 81604000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Sector benchmark
#77 of 165 in Health CareTop 46% of 165This company 81.6M Sector average 170.3M
▼
-52.1% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding decreased 1.7% year-over-year.
- Ranks #89 out of 165 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 81.6M | -1.7% |
| FY2024 | 83.0M | +0.2% |
| FY2023 | 82.9M | -2.0% |
| FY2022 | 84.6M | -1.0% |
| FY2021 | 85.4M | -0.0% |
| FY2020 | 85.5M | -0.7% |
| FY2019 | 86.1M | -1.2% |
| FY2018 | 87.1M | -7.0% |
| FY2017 | 93.6M | -7.7% |
| FY2016 | 101.5M | -6.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026